|
Market Closed -
Other stock markets
|
Pre-market 08:18:18 am | |||
| 28.18 USD | -0.32% |
|
28.16 | -0.07% |
| May. 09 | HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance | MT |
| May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
On January 31, 2023, PrescriberPoint, Inc. closed the transaction. The company has received funding in the transaction. The transaction included participation from new investors Eli Lilly and Company, Pfizer Inc., Adobe Ventures and Mastercard Incorporated.
The round was raised at a post-money valuation of $32,323,995.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 771.6 USD | -0.45% | +2.07% | 695B | ||
| 455.5 USD | +0.16% | +3.26% | 423B | ||
| 28.18 USD | -0.32% | +1.73% | 160B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -2.12% | 160B | |
| +32.36% | 695B | |
| +26.51% | 568B | |
| -4.40% | 361B | |
| +19.46% | 330B | |
| +3.50% | 283B | |
| +17.12% | 239B | |
| +8.01% | 204B | |
| -7.65% | 198B | |
| +8.62% | 168B |
PFIZER, INC. 
